Variation in Fistula Use across Dialysis Facilities: Is It Explained by Case-Mix?

被引:20
|
作者
Tangri, Navdeep [1 ]
Moorthi, Ranjani [1 ]
Tighiouhart, Hocine [2 ]
Meyer, Klemens B. [1 ]
Miskulin, Dana C. [1 ]
机构
[1] Tufts Med Ctr, Div Nephrol, Boston, MA USA
[2] Tufts Med Ctr, Dept Clin Care Res, Boston, MA USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
INCIDENT HEMODIALYSIS-PATIENTS; VASCULAR ACCESS; CLAIMS DATA; STATES;
D O I
10.2215/CJN.04430709
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Arteriovenous fistulas (AVFs) remain the preferred vascular access for hemodialysis patients. Dialysis facilities that fail to meet Centers for Medicare & Medicaid Services goals cite patient case-mix as a reason for low AVF prevalence. This study aimed to determine the magnitude of the variability in AVF usage across dialysis facilities and the extent to which patient case-mix explains it. Design, setting, participants, & measurements: The vascular access used in 10,112 patients dialyzed at 173 Dialysis Clinic Inc. facilities from October 1 to December 31, 2004, was evaluated. The access in use was considered to be an AVF if it was used for > 70% of hemodialysis treatments. Mixed-effects models with a random intercept f or dialysis facilities evaluated the effect of facilities on AVF usage. Sequentially adjusted multivariate models measured the extent to which patient factors (case-mix) explain variation across facilities in AVF rates. Results: 3787 patients (38%) were dialyzed using AVFs. There was a significant facility effect: 7.6% of variation in AVF use was attributable to facility. This was reduced to 7.1% after case-mix adjustment. There were no identified specific facility-level factors that explained the interfacility variation. Conclusions: AVF usage varies across dialysis facilities, and patient case-mix did not reduce this variation. In this study, 92% of the total variation in AVF usage was due to patient factors, but most were not measurable. A combination of patient factors and process indicators should be considered in adjudicating facility performance for this quality indicator. Clin J Am Soc Nephrol 5: 307-313, 2010. doi: 10.2215/CJN.04430709
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条